Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in asian patients with hypertension: A randomized, double-blind, placebo-controlled study

Hypertension

Volumn 63, Issue 4, 2014, Pages 698-705

  Kario, Kazuomi ^a   Sun, Ningling ^b   Chiang, Fu Tien ^c   Supasyndh, Ouppatham ^d   Baek, Sang Hong ^e   Inubushi Molessa, Akiko ^f   Zhang, Ying ^f   Gotou, Hiromi ^g   Lefkowitz, Martin ^f   Zhang, Jack ^f  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^e The Catholic University of Korea   (South Korea)

^f NOVARTIS PHARMA AG   (Switzerland)

^g NOVARTIS PHARMA K K   (Japan)

Author keywords

Asia; blood pressure monitoring ambulatory; hypertension; randomized controlled trial

Indexed keywords

3 (1 BIPHENYL 4 YLMETHYL 3 ETHOXYCARBONYL 1 BUTYLCARBAMOYL)PROPIONIC ACID PLUS VALSARTAN; PLACEBO;

AGED; AMBULATORY MONITORING; ARTHRALGIA; ARTICLE; ASIAN; ATOPIC DERMATITIS; BLOOD PRESSURE MONITORING; CHINA; CONSTIPATION; CONTROLLED STUDY; CYST; DERMAL CYST; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HEMATURIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; JAPAN; KOREA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARYNGITIS; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE; TAIWAN; THAILAND; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION;

ASIA; BLOOD PRESSURE MONITORING, AMBULATORY; HYPERTENSION; RANDOMIZED CONTROLLED TRIAL;

AGED; AMINOBUTYRATES; ANGIOEDEMA; ANGIOTENSIN RECEPTOR ANTAGONISTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHINA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEPRILYSIN; REPUBLIC OF KOREA; TAIWAN; TETRAZOLES; THAILAND; TREATMENT OUTCOME;

EID: 84897030265     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02002     Document Type: Article

References (35)

1. Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S; Asia Pacifc Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacifc region. J Hypertens. 2003;21:707-716.
2. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels. J Hypertens. 2006;24:413-422.
3. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T. Cardiovascular disease and risk factors in Asia: a selected review. Circulation. 2008;118:2702-2709.
4. Macheret F, Heublein D, Costello-Boerrigter LC, et al. Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP. J Am Coll Cardiol. 2012;60:1558-1565.
5. Mangiafco S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC Jr. Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics. Eur Heart J. 2013;34:886-893c.
6. Bevan EG, Connell JM, Doyle J, Carmichael HA, Davies DL, Lorimer AR, McInnes GT. Candoxatril, a neutral endopeptidase inhibitor: effcacy and tolerability in essential hypertension. J Hypertens. 1992;10:607-613.
7. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-328.
8. Campese VM, Lasseter KC, Ferrario CM, Smith WB, Ruddy MC, Grim CE, Smith RD, Vargas R, Habashy MF, Vesterqvist O, Delaney CL, Liao WC. Omapatrilat versus lisinopril: effcacy and neurohormonal profle in salt-sensitive hypertensive patients. Hypertension. 2001;38:1342-1348.
9. Mitchell GF, Izzo JL Jr, Lacourcière Y, Ouellet JP, Neutel J, Qian C, Kerwin LJ, Block AJ, Pfeffer MA. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation. 2002;105:2955-2961.
10. Kostis JB, Packer M, Black HR, Schmieder R, Henry D, Levy E. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens. 2004;17:103-111.
11. Fryer RM, Segreti J, Banfor PN, Widomski DL, Backes BJ, Lin CW, Ballaron SJ, Cox BF, Trevillyan JM, Reinhart GA, von Geldern TW. Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank effcacy of enzymes associated with bradykinin-mediated angio-edema. Br J Pharmacol. 2008;153:947-955.
12. Gu J, Noe A, Chandra P, Al-Fayoumi S, Ligueros-Saylan M, Sarangapani R, Maahs S, Ksander G, Rigel DF, Jeng AY, Lin TH, Zheng W, Dole WP. Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi). J Clin Pharmacol. 2010;50:401-414.
13. Ruilope LM, Dukat A, Böhm M, Lacourcière Y, Gong J, Lefkowitz MP. Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study. Lancet. 2010;375:1255-1266.
14. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, McG Thom S; British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS I V. J Hum Hypertens. 2004;18:139-185.
15. Ogihara T, Kikuchi K, Matsuoka H, et al; Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009;32:3-107.
16. Zusman R, Atlas S, Kochar M, Adler E, Levy E. Effcacy and safety of omapatrilat, a vasopeptidase inhibitor [abstract] Am J Hypertens 1999;12 pt 2:125A.
17. Kario K. Proposal of a new strategy for ambulatory blood pressure profle-based management of resistant hypertension in the era of renal denervation. Hypertens Res. 2013;36:478-484.
18. Ishikawa Y, Ishikawa J, Ishikawa S, Kajii E, Schwartz JE, Pickering TG, Kario K; Jichi Medical School Cohort Investigators Group. Prehypertension and the risk for cardiovascular disease in the Japanese general population: the Jichi Medical School Cohort Study. J Hypertens. 2010;28:1630-1637.
19. Perkovic V, Huxley R, Wu Y, Prabhakaran D, MacMahon S. The burden of blood pressure-related disease: a neglected priority for global health. Hypertension. 2007;50:991-997.
20. Stamler J. The INTERSALT Study: background, methods, fndings, and implications. Am J Clin Nutr. 1997;65(2 suppl):626S-642S.
21. Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res. 2003;26:521-525.
22. Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y. Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population. Circulation. 2008;118:2672-2678.
23. Uzu T, Kimura G, Yamauchi A, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Nishio Y, Maegawa H, Koya D, Haneda M, Kashiwagi A. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens. 2006;24:1627-1632.
24. Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, Chen CS, Chen J, Lu F, Hu D, Rice T, Kelly TN, Hamm LL, Whelton PK, He J; GenSalt Collaborative Research Group. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet. 2009;373:829-835.
25. Wang JG, Kario K, Lau T, Wei YQ, Park CG, Kim CH, Huang J, Zhang W, Li Y, Yan P, Hu D; Asian Pacifc Heart Association. Use of dihydro-pyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientifc statement from the Asian Pacifc Heart Association. Hypertens Res. 2011;34:423-430.
26. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401-1406.
27. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130-135.
28. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852-857.
29. Boggia J, Li Y, Thijs L, et al; International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219-1229.
30. Shimizu M, Ishikawa J, Yano Y, Hoshide S, Eguchi K, Ishikawa S, Shimada K, Kario K. Association between asleep blood pressure and brain natriuretic peptide during antihypertensive treatment: the Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens. 2012;30:1015-1021.
31. Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from non-dipper to dipper in essential hypertension. Circulation. 1999;100:1635-1638.
32. Eguchi K, Hoshide S, Kabutoya T, Shimada K, Kario K. Is very low dose hydrochlorothiazide combined with candesartan effective in uncontrolled hypertensive patients? Blood Press Monit. 2010;15:308-311.
33. Eguchi K, Kario K, Hoshide Y, Hoshide S, Ishikawa J, Morinari M, Ishikawa S, Shimada K. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens. 2004;17:112-117.
34. Li Y, Wang JG, Gao P, Guo H, Nawrot T, Wang G, Qian Y, Staessen JA, Zhu D. Are published characteristics of the ambulatory blood pressure generalizable to rural Chinese? The JingNing population study. Blood Press Monit. 2005;10:125-134.
35. Kario K, Ishikawa J, Eguchi K, Morinari M, Hoshide S, Ishikawa S, Shimada K. Sleep pulse pressure and awake mean pressure as independent predictors for stroke in older hypertensive patients. Am J Hypertens. 2004;17(5 pt 1):439-445.